First Midwest Bank Trust Division cut its stake in shares of Humana Inc. (NYSE:HUM) by 5.0% during the second quarter, Holdings Channel reports. The institutional investor owned 9,791 shares of the insurance provider’s stock after selling 510 shares during the period. First Midwest Bank Trust Division’s holdings in Humana were worth $1,761,000 at the end of the most recent reporting period.
A number of other institutional investors have also made changes to their positions in HUM. Daiwa SB Investments Ltd. raised its position in shares of Humana by 7.5% in the second quarter. Daiwa SB Investments Ltd. now owns 720 shares of the insurance provider’s stock valued at $132,000 after buying an additional 50 shares in the last quarter. Bessemer Group Inc. raised its position in shares of Humana by 392.6% in the first quarter. Bessemer Group Inc. now owns 1,000 shares of the insurance provider’s stock valued at $183,000 after buying an additional 797 shares in the last quarter. Spark Investment Management LLC acquired a new position in shares of Humana during the first quarter valued at $274,000. Rehmann Capital Advisory Group raised its position in shares of Humana by 0.4% in the first quarter. Rehmann Capital Advisory Group now owns 1,506 shares of the insurance provider’s stock valued at $276,000 after buying an additional 6 shares in the last quarter. Finally, Sii Investments Inc. WI acquired a new position in shares of Humana during the first quarter valued at $299,000. Institutional investors and hedge funds own 93.24% of the company’s stock.
Shares of Humana Inc. (NYSE:HUM) traded down 0.43% on Thursday, hitting $175.82. 367,391 shares of the stock were exchanged. The stock has a market cap of $26.21 billion, a price-to-earnings ratio of 27.01 and a beta of 0.91. Humana Inc. has a 1-year low of $150.00 and a 1-year high of $191.65. The stock’s 50-day moving average is $177.23 and its 200-day moving average is $176.36.
Humana (NYSE:HUM) last released its earnings results on Wednesday, August 3rd. The insurance provider reported $2.30 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.23 by $0.07. Humana had a net margin of 1.76% and a return on equity of 11.11%. The company had revenue of $14 billion for the quarter, compared to the consensus estimate of $13.59 billion. During the same quarter in the previous year, the company earned $1.67 EPS. Humana’s quarterly revenue was up 2.0% compared to the same quarter last year. Analysts forecast that Humana Inc. will post $9.26 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Thursday, October 13th will be given a dividend of $0.29 per share. The ex-dividend date is Tuesday, October 11th. This represents a $1.16 dividend on an annualized basis and a dividend yield of 0.66%. Humana’s payout ratio is presently 18.18%.
Several equities research analysts have weighed in on the stock. Zacks Investment Research upgraded shares of Humana from a “hold” rating to a “buy” rating and set a $197.00 target price on the stock in a report on Monday, July 25th. Jefferies Group reiterated a “buy” rating and issued a $220.00 target price (up from $210.00) on shares of Humana in a report on Monday, July 25th. RBC Capital Markets reiterated a “buy” rating and issued a $224.00 target price (up from $220.00) on shares of Humana in a report on Friday, July 22nd. Cantor Fitzgerald reiterated a “buy” rating on shares of Humana in a report on Saturday, July 9th. Finally, Evercore ISI assumed coverage on shares of Humana in a report on Thursday, September 22nd. They issued a “buy” rating and a $200.00 target price on the stock. Six analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Humana has an average rating of “Buy” and a consensus price target of $200.93.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.